1. Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions

   • Christine Ahlström
   • Tobias Kroon
   • Johan Gabrielsson

   Original Paper 10 October 2013 Pages: 623 - 638

   

2. Solution and implementation of distributed lifespan models

   • Gilbert Koch
   • Johannes Schropp

   Original Paper 01 November 2013 Pages: 639 - 650

   

3. A modeling approach for compounds affecting body composition

   • Peter Gennemark
   • Rasmus Jansson-Löfmark
   • Johan Gabrielsson

   Original Paper 25 October 2013 Pages: 651 - 667

   

4. Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats

   • Roberto Heredia-Ortiz
   • Michèle Bouchard

   Original Paper 29 October 2013 Pages: 669 - 682

   

5. On the maintenance of hepatocyte intracellular pH 7.0 in the in-vitro metabolic stability assay

   • Leonid M. Berezhkovskiy
   • Susan Wong
   • Jason S. Halladay

   Original Paper 01 November 2013 Pages: 683 - 689

6. How to avoid unbounded drug accumulation with fractional pharmacokinetics

   • Maud Hennion
   • Emmanuel Hanert

   Original Paper 16 November 2013 Pages: 691 - 700

   

7. Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach

   • Hoi-Kei Lon
   • Dongyang Liu
   • William J. Jusko

   Original Paper 14 November 2013 Pages: 701 - 712